Symrise AG SY1.DE
Composite 47/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 23/100 — a strong mark against it.
Momentum ranks 74/100 — a moderate point in its favour. Balance-sheet strength ranks 61/100 — a slight point in its favour.
Valuation ranks 23/100 — a strong mark against it. Growth ranks 36/100 — a moderate mark against it. Income ranks 44/100 — a slight mark against it.
What the company does Symrise AG is a global supplier of fragrances, flavorings, cosmetic ingredients, and functional solutions across food, beverage, pet food, and personal care markets, organized into Taste, Nutrition & Health and Scent & Care segments.
Key financials Reported margins: gross 37.6%, operating 8.8%, net 5.1%. ROE 6.5%, ROA 4.7%, ROCE 10.3%. Revenue fell 2.4% while EPS rose 12.3%. Debt/Equity 0.70, net debt/EBITDA 2.20, current ratio 2.52.
Stock health Sideravia scores: overall 48.9 (weak quality, rich valuation, positive momentum), quality 44.8, growth 29.4, strength 72.1, valuation 24.2, momentum 75.2, income 54.7. RSI(14) 56.90.
Price vs fair value Symrise trades at a PREMIUM of 36.10% to our fair-value estimate of 56.94 and at a discount of 6.71% to the analyst 12-month target of 95.06. - Valuation percentile 24.2/100 indicates rich pricing (Sideravia). - Forward P/E 22.99 vs trailing 50.04 signals high expectations (Valuation). - Analyst count 18.0 supports the 95.06 target (Analyst 12-month target). - Q2 earnings call highlighted growth initiatives (MarketBeat).
Looking forward Analysts expect a forward P/E of 22.99 and PEG of 0.20, implying earnings growth is priced in, while momentum remains positive with 12-month return 15.88%.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.